SEC Form 3 · accession 0001104659-16-130178
Syros Pharmaceuticals, Inc. · SYRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathanael Gray
10% Owner
Period of report
Jun 29, 2016
Accepted (ET)
Jun 29, 2016 · 6:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001556263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 426,666 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F166,667 shares of the stock are subject to Syros Pharmaceuticals, Inc.'s right of repurchase under certain circumstances. The right of repurchase lapses in its entirely on July 3, 2016.
Remarks
Exhibit 24 - Power of Attorney